Urvi Shah (@urvishahmd) ranks #19 among US multiple myeloma KOLs on X in 2026, by engagement from fellow physicians. 5 physicians shared, quoted or replied to their posts this year. Most-discussed trials in 2026: NUTRIVENTION. CMS Open Payments lists $2,567 in 2025 general payments.

At a Glance
- 1 posts naming a trial since ASH 2025
- 1 trials discussed by name
- Multiple Myeloma: US #19 · 5 physicians engaged
- CMS Open Payments lists $2,567 in 2025 general payments.
This Month
What Urvi Shah has posted in the last 30 days. Updated November 11, 2026.
No trial posts in the last 30 days.
2026 Rankings
| List | US rank | Global rank | Peer Engagement Score | Physicians engaged | Physician engagements | |
|---|---|---|---|---|---|---|
| Multiple Myeloma | #19 | — | 44/100 | 5 | 7 | Full ranking |
What Colleagues Are Saying About Urvi Shah
2026 posts by fellow physicians that mention @urvishahmd, quoted word for word.
#ASHKudos to @UrviShahMD for getting this to finish line in time for #ASH25! High fiber plant-based diets in myeloma precursors: Something our patients ask about, and something we have data for now! QOL, inflam benefits - and in some cases, alteration of #MMsm trajectory! https://t.co/wMuwDmyWR0
Trials Urvi Shah Discussed since ASH 2025
| Trial | Posts | Rank among physicians posting | Latest |
|---|---|---|---|
| NUTRIVENTION | 1 | — | Dec 4, 2025 |
Urvi Shah on NUTRIVENTION
Consumption of a western diet and high BMI are risk factors for progression from pre-malignant phenotypes to cancer MM. In the NUTRIVENTION trial (NCT04920084), we administered a high-fiber, plant-based diet to 23 pts with MM precursor states and elevated BMI. #mmsm #ASH25
Urvi Shah’s Most-Engaged Posts since ASH 2025
Their own 2026 posts that fellow physicians reposted most, quoted word for word.
This is a great strategy for resource limited countries reducing cost significantly. Are infection risks lower too? Look forward to the data #ASH25 @GomezDLeonMD @dgomezalmaguer @rennquevedo https://t.co/kAHq7tDmer
I would like to take this opportunity to thank mentors, collaborators and study participants who believed in the importance of this work. @Matteo_MSB @DrMvandenBrink @LesokhinMD @szusmani @Neil_Iyengar @DrOlaLandgren @Leif_Bergsagel @GiraltSergio Anita D'Souza #ASH25 #mmsm
We show for the first time that a high-fiber diet is a low-risk intervention that may delay progression to myeloma. This project is truly team science and an amazing collaborative effort that spans multiple institutions, 3 countries and 7 years. #ASH25 #mmsm
The intervention was feasible, improved quality of life and modifiable factors: metabolic (BMI, insulin resistance), microbiome (diversity, composition), and immune (inflammation, monocyte subsets). Disease-progression trajectory improved (n=2) or was stable. #mmsm #ASH25